| 03/14/2025 17:30 |
Notice Concerning Commencement of Tender Offer for Share Certificates, etc., of EcoNaviSta Inc. (Securities Code: 5585) |
| 03/07/2025 17:00 |
Eisai Announces Appointments of Corporate Officers |
| 03/07/2025 17:00 |
Notification Regarding Changes in Representative Corporate Officers |
| 03/07/2025 17:00 |
Notice of Nominees for Directors |
| 02/07/2025 12:30 |
FY 2024 (Ending March 31, 2025) Third Quarter Financial Results Reference Data |
| 02/07/2025 12:30 |
CONSOLIDATED FINANCIAL REPORT [IFRS] for the Nine-Month Period Ended December 31, 2024 |
| 11/29/2024 15:30 |
Eisai Announces Completion of Cancellation of Treasury Shares |
| 11/08/2024 12:30 |
Financial Results for the Six-Month Period Ended September 30,2024 Reference Data |
| 11/08/2024 12:30 |
CONSOLIDATED FINANCIAL REPORT [IFRS] for the Six-Month Period Ended September 30, 2024 |
| 10/30/2024 19:45 |
REVENUE OF LEQEMBI (PRELIMINARY BASIS) |
| 10/04/2024 15:30 |
Eisai Announces Status and Completion of Acquisition of Own Shares |
| 10/01/2024 11:30 |
Eisai Announces Status Relating to Acquisition of Own Shares |
| 09/02/2024 11:30 |
Eisai Announces Status Relating to Acquisition of Own Shares |
| 08/02/2024 12:30 |
FY 2024 (Ending March 31, 2025) First Quarter Financial Results Reference Data |
| 08/02/2024 12:30 |
CONSOLIDATED FINANCIAL REPORT [IFRS] for the Three-Month Period Ended June 30, 2024 |
| 08/01/2024 19:45 |
REVENUE OF LEQEMBI (PRELIMINARY BASIS) |
| 08/01/2024 11:30 |
Eisai Announces Status Relating to Acquisition of Own Shares |
| 07/01/2024 15:31 |
EISAI ANNOUNCES MOVE TO SOLO DEVELOPMENT AND COMMERCIALIZATION OF FARLETUZUMAB ECTERIBULIN (FZEC) ANTIBODY DRUG CONJUGATE (ADC) |
| 07/01/2024 11:30 |
Eisai Announces Status Relating to Acquisition of Own Shares |
| 06/27/2024 15:00 |
Position and Policy Regarding Reduction of the Investment Unit of the Company's Shares |
| 06/15/2024 08:00 |
Presentation Material for the Business Report at the 112th Ordinary General Meeting of Shareholders |
| 06/14/2024 17:00 |
Eisai Announces Appointments of Directors and Corporate Officers |
| 06/12/2024 08:00 |
(Correction) Notice of Convocation of the 112th Ordinary General Meeting of Shareholders (2024) |
| 06/12/2024 08:00 |
Correction to "Notice of Convocation of the 112th Ordinary General Meeting of Shareholders (2024)" |
| 06/03/2024 11:30 |
Eisai Announces Status Relating to Acquisition of Own Shares |
| 05/21/2024 08:00 |
Notice of Convocation of the 112th Ordinary General Meeting of Shareholders (2024) |
| 05/15/2024 12:30 |
FY 2023 (Ended March 31, 2024) Full Year Financial Results Reference Data |
| 05/15/2024 12:30 |
CONSOLIDATED FINANCIAL REPORT [IFRS] for Fiscal 2023 (Year Ended March 31, 2024) |
| 05/15/2024 12:30 |
Eisai Announces Acquisition of Own Shares and Cancellation of Treasury Shares |
| 05/15/2024 12:30 |
Notice of Nominees for Directors and Corporate Officers |
| 05/15/2024 12:30 |
Notice Concerning Appointment of New Representative Officer |
